Our analysis of AKT phosphorylation in tumor cells from HM and NHM tumor samples support this hypothesis, by showing in particular similar levels of p-AKT in the HM and NHM groups, and significantly higher than in control tumors devoid of PI3K pathway mutation. The gene discussed is PIK3CG; the disease is neoplasm.